Breast-conserving therapy is safe both within BRCA1/2 mutation carriers and noncarriers with breast cancer in the Chinese population

BACKGROUND: BRCA1/2 mutation is associated with a high risk of breast cancer, which may preclude breast cancer patients with BRCA1/2 mutation from breast-conserving therapy (BCT) [breast-conserving surgery (BCS), followed by radiotherapy, BCT]. It is debatable whether BCT could be a rational choice...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gland Surg
Hlavní autoři: Huang, Xin, Cai, Xiu-Yu, Liu, Jia-Qi, Hao, Wen-Wen, Zhou, Yi-Dong, Wang, Xiang, Xu, Ying, Chen, Chang, Lin, Yan, Wang, Chang-Jun, Song, Yu, Sun, Qiang
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347799/
https://ncbi.nlm.nih.gov/pubmed/32775268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-20-531
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky